Tufts scientists use a stronger tool to tackle a tough long-term prevention question
Eating oily fish may not help prevent Alzheimer's disease after all, according to Tufts researchers. Photo: Shutterstock
Oily fish has long been viewed as “brain food” that supports cognitive health through anti-inflammatory, antioxidant, and vascular mechanisms. That has led researchers to ask whether the benefits of oily fish might extend to Alzheimer’s disease prevention.
But the answer may not be that simple, according to a new study by scientists at the Jean Mayer USDA Human Nutrition Research Center on Aging (HNRCA) at Tufts University.
Titled “Sustained Fish Intake and 21-Year Alzheimer’s Disease Risk: A Target Trial Emulation,” the paper in the American Journal of Epidemiology uses target trial emulation, a method that applies principles from randomized clinical trials to long-term observational data, to obtain insights.
This research approach aims to reduce some biases common in traditional observational studies, which examine effects in more “real world” settings, and have previously been used to study oily fish and Alzheimer’s.
The result, according to José Ordovás, a senior scientist and leader of the Precision Nutrition & Healthy Aging directive at the HNRCA: there was no clear evidence that simply increasing fish intake on its own meaningfully lowers long-term Alzheimer’s risk.
Ordovás was quick to point out that fish is still a healthy food, but the finding suggests it may not be a magic bullet for preventing Alzheimer’s on its own.
“I think the promising part is that this study gives us a sharper answer than older studies could,” Ordovás said. “In other words, we used a stronger method to try to answer a long-term diet question more rigorously.”
Something Fishy in the Data
Alzheimer’s disease affects approximately 6.9 million U.S. adults aged 65 and older, a number projected to more than double by 2060.
Back in 2005, researchers with the Department of Veterans Affairs and the University of California at Los Angeles reported that a diet high in DHA—an omega-3 fatty acid found in relatively high concentrations in cold-water fish—slowed the progression of Alzheimer’s-like disease in mice.
The caveat: It was an animal study, not a human prevention study “Animal studies can be very useful for understanding biological mechanisms,” Ordovás said, “but they do not always predict what happens in people over decades.” In humans, much of the earlier evidence came from observational studies, which can look more favorable because people who eat more fish often differ in many other ways, too. According to Ordovás, “They may have healthier overall diets, different education or income, different smoking and exercise patterns, or better healthcare access.”
Randomized clinical trials (RCTs), on the other hand, administer interventions under controlled conditions and are the gold standard for evaluating causal treatment effects.
Unfortunately, because Alzheimer’s disease develops over decades, a decades-long RCT often isn’t feasible from a logistical or fiscal standpoint. “The field has had a real mismatch,” Ordovás said. “While observational studies often suggested fish or omega-3s might help, randomized trials have mostly been short and largely null.”
Fishing for a New Method
The goal of the new study was not to assume oily fish protects against Alzheimer’s, Ordovás said, but to test that possibility using a design that gets closer to the logic of a randomized trial with humans. In this case, the study design involves asking a more realistic long-term question: Among cognitively healthy older adults, what is the effect of sustained oily fish intake on the risk of Alzheimer’s disease, compared with their usual intake?
The data Ordovás used in his analysis came from the Framingham Heart Study, which has followed cardiovascular disease development in three generations of participants. Specifically, Ordovás’ new analysis emulated a 21-year randomized trial in 2,012 cognitively healthy adults in the Framingham Offspring cohort of the Heart Study.
“Target trial emulation is promising because it helps us study prevention questions that are nearly impossible to randomize for decades,” Ordovás said. “In nutrition research, that’s a big advance, because we often have to choose between short trials and weaker observational studies. This method helps bridge that gap.”
The Verdict on Fish
The next step for researchers is to not just ask whether fish helps in Alzheimer’s prevention, but whether timing, metabolism, genetics, or subgroup differences matter more. He pointed to the apolipoprotein E gene, which has been linked to late-onset Alzheimer's disease.
Ultimately, this new approach helps explain why observational findings may have looked more optimistic in the past, Ordovás added, and points researchers toward better questions: such as when omega-3s matter, for whom, and in what context.
“The real advance is that this new research method helps move the field from broad associations to more precise prevention strategies,” Ordovás said. “That is the kind of evidence we need if we want dietary guidance to become more personalized, more realistic, and more useful for healthy aging.”
